Showing results (1-10 of 1,815) with videos related to
Sort By:
Pageof 182
Journal of Biopharmaceutical Statistics|July 2, 2019
On the relative efficiency of model-assisted designs: a conditional approachRuitao Lin, Ying YuanBiostatistics (Oxford, England)|April 16, 2019
Time-to-event model-assisted designs for dose-finding trials with delayed toxicityRuitao Lin, Ying YuanTherapeutic Innovation & Regulatory Science|August 20, 2025
BOP2-Comb: Bayesian Optimal Phase II Design for Optimizing Doses and Assessing Contribution of Components in Drug CombinationsXiaohan Chi, Ying Yuan, Ruitao LinBiometrics|June 24, 2025
COCA: a randomized Bayesian design integrating dose optimization and component contribution assessment for combination therapiesXiaohan Chi, Ruitao Lin, Ying YuanBayesian Analysis|July 16, 2021
A Phase I-II Basket Trial Design to Optimize Dose-Schedule Regimes Based on Delayed OutcomesRuitao Lin, Peter F Thall, Ying YuanJournal of the American Statistical Association|May 18, 2022
BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival ComparisonsRuitao Lin, Peter F Thall, Ying YuanBiometrics|July 6, 2019
An adaptive trial design to optimize dose-schedule regimes with delayed outcomesRuitao Lin, Peter F Thall, Ying YuanJournal of the National Cancer Institute|March 30, 2019
TOP: Time-to-Event Bayesian Optimal Phase II Trial Design for Cancer ImmunotherapyRuitao Lin, Robert L Coleman, Ying YuanContemporary Clinical Trials|March 11, 2020
Keyboard design for phase I drug-combination trialsHaitao Pan, Ruitao Lin, Yanhong Zhou, et al.Biometrical Journal. Biometrische Zeitschrift|February 17, 2024
A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpointsXiaohan Chi, Ying Yuan, Zhangsheng Yu, et al.Pageof 182